161 related articles for article (PubMed ID: 11844794)
21. Differential modulation of cellular and viral promoters by p73 and p53.
Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
[TBL] [Abstract][Full Text] [Related]
22. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
Di Como CJ; Gaiddon C; Prives C
Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
[TBL] [Abstract][Full Text] [Related]
23. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.
Fontemaggi G; Gurtner A; Strano S; Higashi Y; Sacchi A; Piaggio G; Blandino G
Mol Cell Biol; 2001 Dec; 21(24):8461-70. PubMed ID: 11713281
[TBL] [Abstract][Full Text] [Related]
24. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
25. Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter.
Nakagawa T; Takahashi M; Ozaki T; Watanabe Ki K; Todo S; Mizuguchi H; Hayakawa T; Nakagawara A
Mol Cell Biol; 2002 Apr; 22(8):2575-85. PubMed ID: 11909952
[TBL] [Abstract][Full Text] [Related]
26. N-myc modulates expression of p73 in neuroblastoma.
Zhu X; Wimmer K; Kuick R; Lamb BJ; Motyka S; Jasty R; Castle VP; Hanash SM
Neoplasia; 2002; 4(5):432-9. PubMed ID: 12192602
[TBL] [Abstract][Full Text] [Related]
27. Physical and functional interaction between HCV core protein and the different p73 isoforms.
Alisi A; Giambartolomei S; Cupelli F; Merlo P; Fontemaggi G; Spaziani A; Balsano C
Oncogene; 2003 May; 22(17):2573-80. PubMed ID: 12730672
[TBL] [Abstract][Full Text] [Related]
28. Relief of p53-mediated telomerase suppression by p73.
Toh WH; Kyo S; Sabapathy K
J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
[TBL] [Abstract][Full Text] [Related]
29. The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73.
Liu G; Chen X
J Biol Chem; 2005 May; 280(20):20111-9. PubMed ID: 15769743
[TBL] [Abstract][Full Text] [Related]
30. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis.
Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B
Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258
[TBL] [Abstract][Full Text] [Related]
31. C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter.
Racek T; Mise N; Li Z; Stoll A; Pützer BM
J Biol Chem; 2005 Dec; 280(49):40402-5. PubMed ID: 16234237
[TBL] [Abstract][Full Text] [Related]
32. A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity.
Miyazaki K; Ozaki T; Kato C; Hanamoto T; Fujita T; Irino S; Watanabe K; Nakagawa T; Nakagawara A
Biochem Biophys Res Commun; 2003 Aug; 308(1):106-13. PubMed ID: 12890487
[TBL] [Abstract][Full Text] [Related]
33. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
34. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
[TBL] [Abstract][Full Text] [Related]
35. Characterization of p73 functional domains necessary for transactivation and growth suppression.
Nozell S; Wu Y; McNaughton K; Liu G; Willis A; Paik JC; Chen X
Oncogene; 2003 Jul; 22(28):4333-47. PubMed ID: 12853970
[TBL] [Abstract][Full Text] [Related]
36. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas.
Takada N; Ozaki T; Ichimiya S; Todo S; Nakagawara A
Cancer Res; 1999 Jun; 59(12):2810-4. PubMed ID: 10383137
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
38. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity.
Tomasini R; Seux M; Nowak J; Bontemps C; Carrier A; Dagorn JC; Pébusque MJ; Iovanna JL; Dusetti NJ
Oncogene; 2005 Dec; 24(55):8093-104. PubMed ID: 16044147
[TBL] [Abstract][Full Text] [Related]
39. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.
Kartasheva NN; Lenz-Bauer C; Hartmann O; Schäfer H; Eilers M; Dobbelstein M
Oncogene; 2003 Nov; 22(51):8246-54. PubMed ID: 14614448
[TBL] [Abstract][Full Text] [Related]
40. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
